ACET
Price
$0.67
Change
-$0.05 (-6.94%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
59.86M
47 days until earnings call
NBIX
Price
$102.91
Change
-$5.40 (-4.99%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
13.72B
27 days until earnings call
Ad is loading...

ACET vs NBIX

Header iconACET vs NBIX Comparison
Open Charts ACET vs NBIXBanner chart's image
Adicet Bio
Price$0.67
Change-$0.05 (-6.94%)
Volume$16.48K
Capitalization59.86M
Neurocrine Biosciences
Price$102.91
Change-$5.40 (-4.99%)
Volume$15.84K
Capitalization13.72B
ACET vs NBIX Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. NBIX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and NBIX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ACET: $0.72 vs. NBIX: $108.31)
Brand notoriety: ACET and NBIX are both not notable
ACET represents the Biotechnology, while NBIX is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 47% vs. NBIX: 99%
Market capitalization -- ACET: $59.86M vs. NBIX: $13.72B
ACET [@Biotechnology] is valued at $59.86M. NBIX’s [@Pharmaceuticals: Other] market capitalization is $13.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileNBIX’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • NBIX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than NBIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 2 TA indicator(s) are bullish while NBIX’s TA Score has 4 bullish TA indicator(s).

  • ACET’s TA Score: 2 bullish, 7 bearish.
  • NBIX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NBIX is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а -19.22% price change this week, while NBIX (@Pharmaceuticals: Other) price change was -5.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.00%. For the same industry, the average monthly price growth was +65.26%, and the average quarterly price growth was -10.39%.

Reported Earning Dates

ACET is expected to report earnings on May 20, 2025.

NBIX is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (-3.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($13.7B) has a higher market cap than ACET($59.9M). NBIX YTD gains are higher at: -20.652 vs. ACET (-24.740). NBIX has higher annual earnings (EBITDA): 358M vs. ACET (-110.65M). NBIX has more cash in the bank: 1.03B vs. ACET (176M). ACET has less debt than NBIX: ACET (17.2M) vs NBIX (428M). NBIX has higher revenues than ACET: NBIX (1.89B) vs ACET (0).
ACETNBIXACET / NBIX
Capitalization59.9M13.7B0%
EBITDA-110.65M358M-31%
Gain YTD-24.740-20.652120%
P/E RatioN/A57.20-
Revenue01.89B-
Total Cash176M1.03B17%
Total Debt17.2M428M4%
FUNDAMENTALS RATINGS
ACET vs NBIX: Fundamental Ratings
ACET
NBIX
OUTLOOK RATING
1..100
6469
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
69
Overvalued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
9857
PRICE GROWTH RATING
1..100
9079
P/E GROWTH RATING
1..100
1591
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (36) in the Medical Distributors industry is somewhat better than the same rating for NBIX (69) in the Biotechnology industry. This means that ACET’s stock grew somewhat faster than NBIX’s over the last 12 months.

NBIX's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as ACET (100) in the Medical Distributors industry. This means that NBIX’s stock grew similarly to ACET’s over the last 12 months.

NBIX's SMR Rating (57) in the Biotechnology industry is somewhat better than the same rating for ACET (98) in the Medical Distributors industry. This means that NBIX’s stock grew somewhat faster than ACET’s over the last 12 months.

NBIX's Price Growth Rating (79) in the Biotechnology industry is in the same range as ACET (90) in the Medical Distributors industry. This means that NBIX’s stock grew similarly to ACET’s over the last 12 months.

ACET's P/E Growth Rating (15) in the Medical Distributors industry is significantly better than the same rating for NBIX (91) in the Biotechnology industry. This means that ACET’s stock grew significantly faster than NBIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETNBIX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 10 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 3 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
ETC.X16.120985-0.787310
-4.66%
Ethereum Classic cryptocurrency
BETH.X1796.753400-112.136960
-5.87%
Beacon ETH cryptocurrency
AERGO.X0.050632-0.006180
-10.88%
Aergo cryptocurrency
PEOPLE.X0.013064-0.001720
-11.63%
ConstitutionDAO cryptocurrency
BURGER.X0.008631-0.003136
-26.65%
BurgerCities cryptocurrency

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with ARWR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-1.50%
ARWR - ACET
42%
Loosely correlated
+3.97%
OGI - ACET
41%
Loosely correlated
-0.96%
DVAX - ACET
39%
Loosely correlated
+1.26%
CCCC - ACET
37%
Loosely correlated
+5.92%
CABA - ACET
36%
Loosely correlated
+5.98%
More